Literature DB >> 27317518

Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC).

Gina P Kwon1, Mina Sarah Ally2, Irene Bailey-Healy2, Anthony E Oro2, Jinah Kim3, Anne Lynn Chang2, Sumaira Aasi2, Jean Y Tang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27317518     DOI： 10.1016/j.jaad.2016.02.1235

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  8 in total

1.  [Basal cell carcinoma of the face and scalp : An update on treatment options].

Authors:  B Frerich; F Prall
Journal:  Pathologe       Date:  2018-09       Impact factor: 1.011

Review 2.  Preventing complications in dermatologic surgery: Presurgical concerns.

Authors:  Allen G Strickler; Payal Shah; Shirin Bajaj; Richard Mizuguchi; Rajiv I Nijhawan; Mercy Odueyungbo; Anthony Rossi; Désirée Ratner
Journal:  J Am Acad Dermatol       Date:  2021-01-23       Impact factor: 15.487

3.  Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive Cases.

Authors:  Kai Yuen Wong; Kate Fife; John T Lear; Richard D Price; Amer J Durrani
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-07-21

Review 4.  Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy.

Authors:  Zoe Apalla; Chrysoula Papageorgiou; Aimilios Lallas; Elena Sotiriou; Elizabeth Lazaridou; Efstratios Vakirlis; Athanassios Kyrgidis; Demetrios Ioannides
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-05-10

5.  Basal cell carcinoma: multimodal treatment and the role of neoadjuvant vismodegib.

Authors:  Pedro Carvalho Martins; Rita Valença Filipe; Rui Barbosa; Ivo Julião; Rosa Azevedo; Matilde Ribeiro; Abreu de Sousa
Journal:  Autops Case Rep       Date:  2019-09-27

Review 6.  Targeting the Hedgehog Pathway in Cancer: Current Evidence and Future Perspectives.

Authors:  Daniel Girardi; Adriana Barrichello; Gustavo Fernandes; Allan Pereira
Journal:  Cells       Date:  2019-02-12       Impact factor: 6.600

7.  Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial.

Authors:  Alon Kahana; Shelby P Unsworth; Christopher A Andrews; May P Chan; Scott C Bresler; Christopher K Bichakjian; Alison B Durham; Hakan Demirci; Victor M Elner; Christine C Nelson; Denise S Kim; Shannon S Joseph; Paul L Swiecicki; Francis P Worden
Journal:  Oncologist       Date:  2021-05-31

Review 8.  Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma.

Authors:  Enrico Zelin; Iris Zalaudek; Marina Agozzino; Caterina Dianzani; Arianna Dri; Nicola Di Meo; Roberta Giuffrida; Giovanni Francesco Marangi; Nicoleta Neagu; Paolo Persichetti; Ludovica Toffoli; Claudio Conforti
Journal:  Curr Treat Options Oncol       Date:  2021-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.